Opportunity Information: Apply for PAR 25 275
The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), is seeking applications for a cooperative agreement called "Research Opportunities in Established Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)" under funding opportunity number PAR-25-275. The focus is on supporting cancer epidemiology research that leverages existing, well-established cohort studies, specifically cohorts that have already met their original recruitment targets. In other words, this program is not meant to fund the launch or primary recruitment phase of a new cohort, but rather to capitalize on the scientific value of cohorts that are already built and actively generating long-term data.
Projects funded under this announcement must be hypothesis-driven, meaning applicants are expected to propose clearly defined research questions and analytic plans that use data from an established cohort study. The intent is to produce rigorous epidemiologic evidence across the cancer control continuum, which typically spans prevention, risk assessment, early detection, diagnosis, treatment, survivorship, and outcomes, including factors that influence cancer burden and disparities. While the research questions are central, the FOA also makes it clear that supported projects are expected to include practical elements needed to keep these cohort resources scientifically productive over time, such as cohort maintenance and continued follow-up of participants. This reflects the reality that cohort studies only remain valuable if they can sustain contact, update outcomes and exposures, and preserve high-quality data and biospecimens where applicable.
A key expectation is resource sharing. Applicants are expected not only to analyze existing cohort data, but also to support sharing of the cohort's existing resources. That can include curated datasets, documentation, harmonized variables, biospecimen resources, or other infrastructure that allows the wider scientific community to benefit from these long-term investments. The cooperative agreement mechanism (U01) also signals that NCI anticipates an active partnership role, where NIH program staff may be meaningfully involved in coordinating, guiding, or collaborating on certain aspects of the funded effort, consistent with how U-series cooperative agreements typically operate.
This opportunity is categorized as discretionary funding and uses the cooperative agreement funding instrument. The activity category is listed under education and health, and the CFDA (assistance listing) number associated with it is 93.393. The opportunity explicitly states that clinical trials are not allowed, so the work proposed should be epidemiologic and observational or otherwise non-trial in nature, rather than interventional studies assigning participants to treatments or prevention strategies.
Eligibility is broad and includes many types of U.S. organizations and governmental entities. Eligible applicants include state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; and Native American tribal organizations that are not federally recognized tribal governments. It also includes public housing authorities and Indian housing authorities, as well as nonprofits both with and without 501(c)(3) status (as long as they are not institutions of higher education). For-profit organizations (other than small businesses) and small businesses are also eligible, along with an "other" category that can capture additional eligible entity types described in the announcement.
In addition, the FOA highlights several specific applicant groups as eligible, emphasizing inclusivity of organizations that serve or represent populations historically underrepresented in biomedical research and public health funding. These include Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISIs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs); Indian/Native American Tribal Governments other than federally recognized entities; faith-based or community-based organizations; regional organizations; U.S. territories or possessions; eligible federal agencies; and even non-U.S. entities (foreign organizations). This breadth signals that NCI is open to strong cohort-based cancer epidemiology science originating from a wide range of institutional settings, including international contexts when appropriate.
The opportunity was created on November 19, 2024, and lists an original closing date of February 28, 2025. The posted summary does not specify an award ceiling or the expected number of awards, so applicants would typically need to consult the full FOA text for budget guidance, project period expectations, and any limits or preferences related to scope, costs, and anticipated program capacity.Apply for PAR 25 275
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Research Opportunities in Established Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.393.
- This funding opportunity was created on 2024-11-19.
- Applicants must submit their applications by 2025-02-28. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
1) What is the name of this funding opportunity?
The opportunity is titled "Research Opportunities in Established Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)."
2) What is the funding opportunity number (FOA number)?
The funding opportunity number is PAR-25-275.
3) Which federal agency is offering this opportunity?
This opportunity is offered by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH).
4) What type of award mechanism is being used?
The mechanism is a cooperative agreement (U01). This generally indicates substantial involvement by NIH/NCI program staff in coordinating, guiding, or collaborating on certain aspects of the funded work, consistent with how U-series cooperative agreements operate.
5) Is this a clinical trial funding opportunity?
No. The opportunity explicitly states "Clinical Trial Not Allowed," meaning proposed work should be non-trial in nature (for example, observational or other non-interventional epidemiologic research) and should not involve assigning participants to interventions.
6) What is the main scientific focus of this program?
The focus is to support cancer epidemiology research that leverages existing, well-established cohort studies, particularly cohorts that have already met their original recruitment targets and are generating long-term data.
7) Does this program fund starting a new cohort study?
No. The program is not intended to fund the launch of a new cohort or support the primary recruitment phase of a new cohort. It is designed to capitalize on the scientific value of cohorts that are already established.
8) What does "established cohort" mean in this context?
Based on the description provided, an established cohort is a well-established cohort study that has already met its original recruitment targets and is positioned to support long-term follow-up and analysis.
9) What kind of research approach is expected?
Projects must be hypothesis-driven. Applicants are expected to propose clearly defined research questions and analytic plans that use data from an established cohort study.
10) What parts of the cancer control continuum are relevant?
The intent is to produce rigorous epidemiologic evidence across the cancer control continuum, including prevention, risk assessment, early detection, diagnosis, treatment, survivorship, and outcomes. The description also notes interest in factors that influence cancer burden and disparities.
11) Beyond analysis, what practical project elements are expected?
In addition to the research questions and analyses, projects are expected to include practical elements needed to keep cohort resources scientifically productive over time. Examples mentioned include cohort maintenance and continued follow-up of participants (such as sustaining contact and updating outcomes and exposures), and preserving high-quality data and biospecimens where applicable.
12) Is resource sharing part of the expectation?
Yes. A key expectation is resource sharing. Applicants are expected not only to analyze existing cohort data, but also to support sharing of the cohort's existing resources so the broader scientific community can benefit.
13) What kinds of cohort resources may be shared under this program?
The description lists examples such as curated datasets, documentation, harmonized variables, biospecimen resources, and other infrastructure that helps others use and benefit from the cohort.
14) What is the assistance listing (CFDA) number associated with this opportunity?
The associated assistance listing (CFDA) number is 93.393.
15) How is this opportunity categorized in terms of funding type and activity area?
It is described as discretionary funding using a cooperative agreement funding instrument. The activity category is listed under education and health.
16) Who is eligible to apply?
Eligibility is broad and includes many types of U.S. organizations and governmental entities. Examples listed include state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; and Native American tribal organizations that are not federally recognized tribal governments.
17) Are housing authorities eligible?
Yes. The description includes public housing authorities and Indian housing authorities as eligible applicants.
18) Are nonprofit organizations eligible?
Yes. Nonprofits with and without 501(c)(3) status are listed as eligible, as long as they are not institutions of higher education.
19) Are for-profit organizations eligible?
Yes. For-profit organizations (other than small businesses) are listed as eligible, and small businesses are also listed as eligible.
20) Are tribal and tribally affiliated entities specifically included?
Yes. The eligibility description includes federally recognized Native American tribal governments, Native American tribal organizations that are not federally recognized tribal governments, and it further highlights Tribally Controlled Colleges and Universities (TCCUs) and Indian/Native American Tribal Governments other than federally recognized entities.
21) Are minority-serving institutions and organizations serving underrepresented populations eligible?
Yes. The FOA highlights eligibility for several groups, including Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISIs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); and Tribally Controlled Colleges and Universities (TCCUs).
22) Are faith-based or community-based organizations eligible?
Yes. Faith-based or community-based organizations are specifically highlighted as eligible in the description.
23) Are U.S. territories or possessions eligible?
Yes. U.S. territories or possessions are highlighted among the eligible applicant groups.
24) Are federal agencies eligible?
Yes. Eligible federal agencies are highlighted among eligible applicant groups.
25) Can non-U.S. (foreign) organizations apply?
Yes. The description explicitly includes non-U.S. entities (foreign organizations) as eligible.
26) When was this opportunity created?
The opportunity was created on November 19, 2024.
27) What is the original closing date listed?
The original closing date listed in the provided summary is February 28, 2025.
28) Is the award ceiling or the number of expected awards provided in the summary?
No. The posted summary does not specify an award ceiling or the expected number of awards.
29) Where would an applicant typically find budget guidance and project period expectations?
Since the posted summary does not include an award ceiling, number of awards, or detailed budget guidance, applicants would typically need to consult the full FOA text for budget guidance, expected project period, and any limits or preferences related to scope and costs.
30) What is the overall purpose of supporting cohort maintenance and follow-up under this program?
The description emphasizes that cohort studies remain valuable only if they can sustain contact with participants, update outcomes and exposures, and preserve high-quality data and biospecimens (where applicable). The program supports work that keeps these established cohort resources productive over time while answering hypothesis-driven questions.
Browse more opportunities from the same category: Education, Health
Next opportunity: Ending HIV as a public health threat by sustaining and accelerating a comprehensive HIV and TB response in India under the President's Emergency Plan for AIDS Relief (PEPFAR)
Previous opportunity: Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 25 275
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 25 275) also looked into and applied for these:
| Funding Opportunity |
|---|
| Advancing Genomic Medicine Research (R01 Clinical Trial Optional) Apply for RFA HG 25 002 Funding Number: RFA HG 25 002 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Biology of Bladder Cancer (R01 Clinical Trial Optional) Apply for PAR 25 129 Funding Number: PAR 25 129 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Biology of Bladder Cancer (R21 Clinical Trial Optional) Apply for PAR 25 128 Funding Number: PAR 25 128 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed) Apply for RFA DA 26 034 Funding Number: RFA DA 26 034 Agency: National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| NCI Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed) Apply for PAR 25 135 Funding Number: PAR 25 135 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Co-infection and Cancer (R21 Clinical Trial Not Allowed) Apply for PAR 25 083 Funding Number: PAR 25 083 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts (U01 Clinical Trial Not Allowed) Apply for PAR 25 186 Funding Number: PAR 25 186 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional) Apply for PAR 25 235 Funding Number: PAR 25 235 Agency: National Institutes of Health Category: Education, Health Funding Amount: $250,000 |
| Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R01 Clinical Trial Not Allowed) Apply for PAR 25 107 Funding Number: PAR 25 107 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed) Apply for PAR 25 106 Funding Number: PAR 25 106 Agency: National Institutes of Health Category: Education, Health Funding Amount: $475,000 |
| NIDA Avant-Garde Program for HIV and Substance Use Disorder Research (DP1 Clinical Trial Optional) Apply for PAR 25 261 Funding Number: PAR 25 261 Agency: National Institutes of Health Category: Education, Health Funding Amount: $700,000 |
| Role of T-Cells in HIV CNS Reservoir Seeding, Persistence, and Neuropathogenesis (R01 Clinical Trial Not Allowed) Apply for RFA MH 26 110 Funding Number: RFA MH 26 110 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Role of T-Cells in HIV CNS Reservoir Seeding, Persistence, and Neuropathogenesis (R21 Clinical Trial Not Allowed) Apply for RFA MH 26 111 Funding Number: RFA MH 26 111 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Limited Competition: NIH Neuroscience Doctoral Readiness Program (DR. Program) (R25 Clinical Trial Not Allowed) Apply for RFA NS 25 027 Funding Number: RFA NS 25 027 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Medical Devices for Pediatric Population Affected by Substance Use and Addiction (R43 - Clinical Trials Optional) Apply for RFA DA 26 016 Funding Number: RFA DA 26 016 Agency: National Institutes of Health Category: Education, Health Funding Amount: $400,000 |
| NINR Resources and Related Research Projects in Firearm Injury Prevention (R24 Clinical Trial Not Allowed) Apply for RFA NR 25 002 Funding Number: RFA NR 25 002 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Medical Devices for Pediatric Population Affected by Substance Use and Addiction (R41 - Clinical Trials Optional) Apply for RFA DA 26 017 Funding Number: RFA DA 26 017 Agency: National Institutes of Health Category: Education, Health Funding Amount: $400,000 |
| Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required) Apply for PAR 25 254 Funding Number: PAR 25 254 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed) Apply for PAR 25 248 Funding Number: PAR 25 248 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R21 Clinical Trial Optional) Apply for PA 25 295 Funding Number: PA 25 295 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 25 275", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
